TAVR Home Monitoring Pathway

Elevate the standard of care

Elevate and create a new standard of excellence in care with Philips BioTel Heart Mobile Cardiac Outpatient Telemetry (MCOT) TAVR Home Monitoring Pathway.
Nearly 1/3 of the transfemoral TAVR patients who died within 30 days post-procedure were after hospital discharge1
Benefits
Decrease length-of-stay (LOS) 2
Reduce risk of sudden death 2
Avoid unnecessary PPM implantations 3

Detect DH-AVB post TAVR

Protect patients from potential post-discharge complications, such as sudden death due to delayed high-grade heart block (DH-AVB), that can occur days to weeks after hospital discharge through the implementation of MCOT.​

10%

post-TAVR outpatient MCOT detected high-grade heart block.4

9%

of patients require placement of PPMs post discharge.4

6 days

(Range 3-24 Days)

Median time to develop (DH-AVB) post-procedure.4

Philips BioTel Heart

TAVR Home Monitoring Pathway

Philips BioTel Heart TAVR Home Monitoring Pathway enables your organization to meet the 2020 ACC Expert Consensus Guidelines on TAVR which recommends post-TAVR outpatient remote monitoring within 48 hours if the patient is without clear pacemaker indications but is at risk for DH-AVB.

CASE STUDY AND WEBINAR

Northwell Health post-TAVR monitoring experience Comprehensive TAVR monitoring program

Learn how Kabir Bhasin, MD, Electrophysiologist and Director of Clinical Education, Lenox Hill Hospital at Northwell Health was able to leverage MCOT post-TAVR monitoring to reduce unnecessary PPM implantation, decrease LOS by 1.6 days and improve overall patient outcomes.

References:
1. Saif Anwaruddin, Nimesh D. Desai, et al. Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement: An STS/ACC TVT Analysis Coronary. J Am Coll Cardiol Cardiovasc Interv. 2021 Feb, 14 (3) 261–274
2. Based on Physician Testimonial: Kabir Bhasin, MD, Electrophysiologist and Director of Clinical Education, Lenox Hill Hospital at Northwell Health. Northwell Health post-TAVR Monitoring Experience Comprehensive TAVR monitoring program. BioTelemetry, September 11, 2021 https://www.gobio.com/tavr/.
3. Lilly S, Deshmukh A, Epstein A, et al. 2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2020;76(20):2391-2411. doi:10.1016/j.jacc.2020.08.050
4. Mobile Cardiac Telemetry utilized in this study was the ACT (Ambulatory Cardiac Telemetry) Monitor by BioTel Heart. Reference: 2. Ream K, Sandhu A, Valle J, et al. Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2019;73(20):2538–2547.

Ivermectin